Skip to content

ANNOTeM (acute neurological care in North-East Germany with telemedical support). Effects of telemedicine-supported emergency care for acute neurological diseases

ANNOTeM (acute neurological care in North-East Germany with telemedical support). Effects of telemedicine-supported emergency care for acute neurological diseases - ANNOTeM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013067
Enrollment
1820
Registered
2017-11-16
Start date
2017-11-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I60 I61 I62 I63 I64 S06 S07 S14 S24 S34 G82 G00 G01 G02 G03 G06 G07 G41 R40

Interventions

Group 1: Telemedicine-supported care model with sustainable strengthening of regional structures by implementation of Acute-Neuro-Units, standardised procedures, continuous further training. Group 2:

Sponsors

Charité Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Control group: All patients of the health insurance companies AOK Nordost, BARMER und Techniker Krankenkasse, who have defined primary diagnoses (stroke: ICD-10: I60, I61, I62, I63, I64; head trauma: ICD-10: S06, S07; acute spinal cord injury ICD-10: S14, S24, S34, G82; Bacterial or viral meningitis/encephalitis, ICD-10: A39.0-2, A85-87, G00-G03, G06, G07; unclear disturbance of consciousness and status epilepticus: ICD-10: G41, R40) were included in participating clinics during the control period November 2014 through November 2016. Intervention group: All patients of the health insurance funds AOK Nordost, BARMER und Techniker Krankenkasse who have been admitted to the participating clinics with defined main diagnoses (see above) in the project period October (at some clinics December 2017 up to and including February 2020.

Exclusion criteria

Exclusion criteria: non-acute syndromes (>24h), non-neurological syndromes

Design outcomes

Primary

MeasureTime frame
Time to death or first-time care at home or paid care support for the first time within 90 days after the index event

Secondary

MeasureTime frame
Extended observation period to 120 days; Subgroup analyses for the events death, home care and first-time reimbursed care support; Subgroup analyses for stroke

Countries

Germany

Contacts

Public ContactJoachim Weber

Charité Universitätsmedizin Berlin

joachim.weber@charite.de+49 30450543524

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 17, 2026